Background: Hypertension represents one of the most prevalent risk factors associated with ischemic stroke (IS).
Methods: A total of 102 essential hypertension (EH) patients without IS and 155 EH patients with IS were enrolled. Logistic regression analysis was performed to identify independent risk factors influencing IS. Kaplan-Meier survival analysis was used to evaluate the association between miR-127-3p expression and no recurrence in IS patients. Cox regression was applied to determine independent predictors of recurrence in IS patients. The BV-2 microglia cell line was utilized to construct an oxygen-glucose deprivation/reoxygenation (OGD/R) model, simulating ischemic injury in vitro. Flow cytometry was employed to measure cell apoptosis, while enzyme-linked immunosorbent assay was used to quantify inflammatory cytokine levels. Biochemical assay kits were applied to detect the levels of superoxide dismutase, reactive oxygen species, and malondialdehyde. Dual-luciferase reporter assays were conducted to confirm the targeting relationship.
Results: miR-127-3p was significantly upregulated in EH+IS patients and demonstrated high diagnostic value. Patients with high miR-127-3p expression exhibited a significantly increased risk of recurrence. Mechanistically, miR-127-3p played a critical role in promoting inflammation, oxidative stress, and apoptosis in OGD/R-induced neuronal injury. Akt3 was identified as a direct functional target of miR-127-3p. Suppression of miR-127-3p relieved its inhibitory effect on Akt3, thereby activating the neuroprotective function of Akt3. When Akt3 was knocked down, the protective effects mediated by the miR-127-3p inhibitor were reversed.
Conclusions: The miR-127-3p/Akt3 axis played a critical role in the regulatory mechanisms associated with EH complicated by IS.
Keywords: Akt3; hypertension; ischemic stroke; miR-127-3p; oxidative stress.
© The Author(s) 2025. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.